Prescribing approach Weekly injections for most GLP-1 protocols Start low, titrate based on response and side effects Ongoing monitoring with our clinical team in Oswego Contraindications (examples) We do not initiate GLP-1 therapy if you have, for example: Personal or family history of medullary thyroid cancer MEN 2 (Multiple Endocrine Neoplasia type 2) Pregnancy or plans to become pregnant History of pancreatitis or severe gastroparesis Full screening happens at consultation
That doesn't mean the drug isn't working
In fact, I would argue convenience is a big friend to GLP-1 consumers. Recent GLP-1 research by Circana found the average user is on the medication between three to six months, and those three to six months are so incredibly important because the other thing that happens is they embrace the food and beverage changes during that time frame more than any other time frame (on GLP-1 medication), Lyons Wyatt said
A realistic way to think about GLP-1 medications: They improve the environment around lipedema (not the diseased tissue itself) GLP-1 belongs in the category of supportive tools similar to anti-inflammatory diet, metabolic care, and mobility support
The segment is driven by the driven by increasing incidence of type 2 diabetes uptake, widespread approvals, and clinical competence
The transition to brand-name only (Wegovy and Zepbound) significantly increased costs for patients, with some reporting their monthly bills doubled or tripled